VIIV HEALTHCARE ANNOUNCES HEALTH CANADA APPROVAL FOR APRETUDE (CABOTEGRAVIR TABLETS AND EXTENDED RELEASE INJECTABLE SUSPENSION) FOR PRE-EXPOSURE PROPHYLAXIS (PREP) TO REDUCE THE RISK OF SEXUALLY ACQUIRED HIV
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- Viiv Healthcare Announces Health Canada Approval For Apretude (C…